NOVOSTE BETA-CATH SYSTEM
FDA premarket approval P000018/S027 · decided 2003-10-23
Approval details
- PMA number
- P000018
- Supplement
- S027
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- NOVOSTE BETA-CATH SYSTEM
- Generic name
- Intravascular radiation delivery system
- Applicant
- Best Vascular, Inc.
- Date received
- 2002-10-21
- Decision date
- 2003-10-23
- Days to decision
- 367 days
- Decision code
- APPR
- Product code
- MOU
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Norcross, GA
- Statement
- APPROVAL TO CHANGE AN ELECTRONIC DATA MANAGEMENT SYSTEM, REFERRED TO AS THE BETACAL SYSTEM.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.